[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100633171":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":11,"centralContacts":26,"locations":32,"responsibleParty":51,"collaborators":11,"id":54,"slug":55,"hasResults":56,"nctId":57,"briefTitle":58,"officialTitle":59,"acronym":11,"eligibilityCriteria":60,"healthyVolunteers":61,"sex":62,"minAge":63,"maxAge":64,"enrollmentInfo":65,"targetDuration":11,"studyType":68,"phases":69,"briefSummary":71,"conditions":72,"keywords":11,"overallStatus":35,"whyStopped":11,"lastUpdateSubmitDate":74,"lastUpdatePostDateStruct":75,"startDateStruct":78,"completionDateStruct":80,"leadSponsor":82,"locationsCount":83},{"fullName":5,"class":6},"Zagazig University","OTHER_GOV",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"injectable PLLA","EXPERIMENTAL",null,[13],"Drug: injectable PLLA",{"label":15,"type":10,"description":11,"interventionNames":16},"PLLA threads",[17],"Drug: PLLA threads",[19,23],{"type":20,"name":9,"description":21,"armGroupLabels":22,"otherNames":11},"DRUG","The vial was reconstituted with 8 mL of bacteriostatic sterile water for injection (BSWFI). After at least 2 hours, 2 mL of lidocaine (1-2%) with epinephrine was added, making the total solution volume 10 mL. One hour later, the vial was gently shaken, and the syringes were prepared for injection.\n\nThe injection was given using 28-G needles beneath each scar with a serial injection technique during each session.",[9],{"type":20,"name":15,"description":24,"armGroupLabels":25,"otherNames":11},"On the right side of the face, PLLA threads were used in a single session. Approximately 8-10 Everline PLLA mono-threads",[15],[27],{"name":28,"role":29,"phone":30,"phoneExt":11,"email":31},"Reham Essam, MD","CONTACT","+201097709477","rereessam22@gmail.com",[33],{"facility":34,"status":35,"city":36,"state":37,"zip":38,"country":39,"countryCode":40,"cosmosGeoPoint":41,"geoPoint":46,"contacts":47},"Zagazig University Hospitals","RECRUITING","Zagazig","Sharqia Province","2543","Egypt","EG",{"type":42,"coordinates":43},"Point",[44,45],31.502,30.58768,{"lat":45,"lon":44},[48],{"name":49,"role":29,"phone":50,"phoneExt":11,"email":31},"Reham Essam","01097709477",{"type":52,"investigatorFullName":49,"investigatorTitle":53,"investigatorAffiliation":5,"oldNameTitle":11,"oldOrganization":11},"PRINCIPAL_INVESTIGATOR","Ass.prof","100633171","poly-l-lactic-acid-in-atrophic-acne-scars-100633171",false,"NCT07523217","Poly-L-Lactic Acid in Atrophic Acne Scars","Poly-L-Lactic Acid: A Comparative Study of Injectable and Thread-Based Delivery in Atrophic Acne Scars","Inclusion Criteria:\n\n* included adult patients (≥18 years) of both sexes presenting with clinically diagnosed atrophic acne scars (Grades 2-4 according to the Goodman and Baron classification)\n\nExclusion Criteria:\n\n* active acne lesions, pregnancy or lactation, bleeding disorders, keloid tendency, systemic diseases affecting wound healing, recent acne scar treatment within the past six months, and known hypersensitivity to PLLA components.",true,"ALL","18 Years","40 Years",{"count":66,"type":67},52,"ESTIMATED","INTERVENTIONAL",[70],"NA","Background: Management of atrophic acne scars remains challenging due to their heterogeneous morphology and suboptimal response to conventional therapies. Poly-L-lactic acid (PLLA), a biostimulatory agent, promotes neocollagenesis and has emerged as a promising therapeutic option. However, comparative data on different delivery modalities of PLLA and their effects on dermal remodeling and skin physiology remain limited.\n\nObjective: To compare two delivery modalities of PLLA (injectable versus mono-thread) and evaluate their effects on dermal remodeling, clinical outcomes, and safety in atrophic acne scars.\n\nMethods: This prospective split-face study included 24 patients with atrophic acne scars. The right facial side was treated with a single session of PLLA mono-threads, while the left side received two sessions of injectable PLLA at 6-week intervals. Clinical outcomes were assessed using Goodman and Baron's qualitative and quantitative grading systems over a 3-month follow-up period.",[73],"Atrophic Acne Scarring","2026-04-03",{"date":76,"type":77},"2026-04-13","ACTUAL",{"date":79,"type":77},"2024-03-15",{"date":81,"type":67},"2027-03-15",{"name":5,"class":6},1]